Chief Executive John Glencross featured on BBC Newsnight

John Glencross was asked by BBC Newsnight to comment on the position for investors during the ongoing Brexit negotiations. To watch the short clip please see below. [youtube id=”StTC1jD2Emc” align=”center” mode=”normal” autoplay=”no”]

Spotlight On: Blu Wireless Technology

As part of our ‘Spotlight On’ series, we focus on Blu Wireless Technology a technology company, developing semiconductor designs for the next generation of high speed wireless data transfer. Calculus Capital completed a £2.4m investment in Blu Wireless (‘BWT’) in June 2017, … Continued

Spotlight On: AnTech

As part of our ‘Spotlight On’ series, we focus on AnTech a specialist engineering company in the oil and gas industry. AnTech Limited has two different businesses: manufacturing products for use mainly in oil and gas production (as opposed to drilling) and … Continued

Benito’s Hat News Article in Today’s City AM

News of Benito’s Hat growth investment makes the headlines in this morning’s publication of City AM! Read more via the link below. Benito's Hat eyes expansion after securing new funding — City A.M. (@CityAM) August 6, 2018

Mologic announces diagnostic clinical trial for Cystic Fibrosis

Calculus Capital portfolio company Mologic announced today that they have commenced a clinical trial to evaluate the company’s urine-based diagnostic, HeadsUp, in monitoring pulmonary exacerbation in cystic fibrosis (CF) patients. The study aims to identify five urinary biomarkers associated with … Continued

Calculus invests £2m in Oxford BioTherapeutics

London, 3 August 2018: Calculus Capital has invested £2m in Oxford BioTherapeutics (OBT), a clinical-stage oncology company that is developing next-generation cancer treatments. OBT has a strong pipeline of ‘immune-oncology’ (IO) therapies that are intended to provide more targeted, specialised … Continued